Is hyperthermia combined with radiotherapy adequate in elderly patients with muscle-invasive bladder cancers? Thermo-radiobiological implications from an audit of initial results

References

• Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, The Globocan Project. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 Lyon, France: International Agency for Research on Cancer; 2013. Available from http://globocan.iarc.fr. (accessed 17 November 2015)
   Google Scholar
• Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, et al. Bladder cancer. J Natl Compr Canc Netw 2013;11:446–75
   PubMed Web of Science ®Google Scholar
• Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013;63:45–57
   PubMed Web of Science ®Google Scholar
• Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2013 guidelines. Eur Urol 2014;65:778–92
   PubMed Web of Science ®Google Scholar
• Martini T, Mayr R, Wehrberger C, Dechet C, Lodde M, Palermo S, et al. Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer. Int Braz J Urol 2013;39:622–30
   PubMed Web of Science ®Google Scholar
• Koga F, Kihara K. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: A contemporary review. Int J Urol 2012;19:388–401
   PubMed Web of Science ®Google Scholar
• Yoo S, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Does radical cystectomy improve overall survival in octogenarians with muscle-invasive bladder cancer? Korean J Urol 2011;52:446–51
   PubMedGoogle Scholar
• Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: A pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 2014;32:3801–9
   PubMed Web of Science ®Google Scholar
• James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012;366:1477–88
   PubMed Web of Science ®Google Scholar
• Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, et al. Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: Results of the BC2001 trial (CRUK/01/004). Int J Radiat Oncol Biol Phys 2013;87:261–9
   PubMed Web of Science ®Google Scholar
• Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): A review of the literature and a practical approach to therapy. BJU Int 2013;112:13–25
   PubMed Web of Science ®Google Scholar
• Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rodel CM, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: A systematic review. Eur Urol 2014;66:120–37
   PubMed Web of Science ®Google Scholar
• Datta NR, Ordonez SG, Gaipl US, Paulides MM, Crezee H, Gellermann J, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future. Cancer Treat Rev 2015;41:742–53
   PubMed Web of Science ®Google Scholar
• Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 2011;107:912–18
   PubMed Web of Science ®Google Scholar
• Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60:81–93
   PubMed Web of Science ®Google Scholar
• Masunaga SI, Hiraoka M, Akuta K, Nishimura Y, Nagata Y, Jo S, et al. Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer. Int J Hyperthermia 1994;10:31–40
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25
   PubMed Web of Science ®Google Scholar
• Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, et al. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 1990;6:719–40
   PubMed Web of Science ®Google Scholar
• Matsui K, Takebayashi S, Watai K, Kakehi M, Kubota Y, Yao M, et al. Combination radiotherapy of urinary bladder carcinoma with chemohyperthermia. Int J Hyperthermia 1991;7:19–26
   PubMed Web of Science ®Google Scholar
• Wittlinger M, Rodel CM, Weiss C, Krause SF, Kuhn R, Fietkau R, et al. Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009;93:358–63
   PubMed Web of Science ®Google Scholar
• Franken NA, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, et al. Cell survival and radiosensitisation: Modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol 2013;42:1501–15
   PubMed Web of Science ®Google Scholar
• ICRU. Prescribing, Recording, and Reporting Photon Beam Therapy (ICRU Report 50). Bethesda, MD: ICRU, 1993
   Google Scholar
• ICRU. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), ICRU Report 62. Bethesda, MD: ICRU, 1999
   Google Scholar
• Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010;83:554–68
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163–70
   PubMed Web of Science ®Google Scholar
• Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998;14:125–33
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 2011;187:605–10
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services NCI. Common Termionology Criteria for Adverse Events (CTCAE) version 4.0. Bethesda, MD: National Institutes of Health, 2010. version 4.03: Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf (accessed 17 November 2015)
   Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47
   PubMed Web of Science ®Google Scholar
• Kiss B, Burkhard FC, Thalmann GN. Open radical cystectomy: Still the gold standard for muscle invasive bladder cancer. World J Urol 2015;Nov 19 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Izquierdo L, Peri L, Leon P, Ramirez-Backhaus M, Manning T, Alcaraz A, et al. The role of cystectomy in elderly patients – a multicentre analysis. BJU Int 2015;116(Suppl3):73–9
   PubMed Web of Science ®Google Scholar
• Bjornsson O, Gudmundsson EO, Marteinsson VT, Jonsson E. Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study. Scand J Urol 2015;Sept 21:1–6 [Epub ahead of print]
   Google Scholar
• Garde H, Ciappara M, Galante I, Fuentes Ferrer M, Gomez A, Blazquez J, et al. Radical cystectomy in octogenarian patients: A difficult decision to take. Urol Int 2015;94:390–3
   PubMed Web of Science ®Google Scholar
• Zakaria AS, Santos F, Tanguay S, Kassouf W, Aprikian AG. Radical cystectomy in patients over 80 years old in Quebec: A population-based study of outcomes. J Surg Oncol 2015;111:917–22
   PubMed Web of Science ®Google Scholar
• Zagouri F, Peroukidis S, Tzannis K, Kouloulias V, Bamias A. Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG). Crit Rev Oncol Hematol 2015;93:36–49
   PubMed Web of Science ®Google Scholar
• Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: The MGH experience. Eur Urol 2012;61:705–11
   PubMed Web of Science ®Google Scholar
• Linthorst M, van Geel AN, Baaijens M, Ameziane A, Ghidey W, van Rhoon GC, et al. Re-irradiation and hyperthermia after surgery for recurrent breast cancer. Radiother Oncol 2013;109:188–93
   PubMed Web of Science ®Google Scholar
• van der Zee J, De Bruijne M, Mens JW, Ameziane A, Broekmeyer-Reurink MP, Drizdal T, et al. Reirradiation combined with hyperthermia in breast cancer recurrences: Overview of experience in Erasmus MC. Int J Hyperthermia 2010;26:638–48
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology, bladder cancer 2015. version 2.2015. Available from http://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf (accessed 4 December 2015)
   Google Scholar